Correlation Between Moleculin Biotech and Cyclacel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Moleculin Biotech and Cyclacel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moleculin Biotech and Cyclacel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moleculin Biotech and Cyclacel Pharmaceuticals, you can compare the effects of market volatilities on Moleculin Biotech and Cyclacel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moleculin Biotech with a short position of Cyclacel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moleculin Biotech and Cyclacel Pharmaceuticals.
Diversification Opportunities for Moleculin Biotech and Cyclacel Pharmaceuticals
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Moleculin and Cyclacel is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Moleculin Biotech and Cyclacel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclacel Pharmaceuticals and Moleculin Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moleculin Biotech are associated (or correlated) with Cyclacel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclacel Pharmaceuticals has no effect on the direction of Moleculin Biotech i.e., Moleculin Biotech and Cyclacel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Moleculin Biotech and Cyclacel Pharmaceuticals
Given the investment horizon of 90 days Moleculin Biotech is expected to generate 0.98 times more return on investment than Cyclacel Pharmaceuticals. However, Moleculin Biotech is 1.02 times less risky than Cyclacel Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Cyclacel Pharmaceuticals is currently generating about -0.4 per unit of risk. If you would invest 262.00 in Moleculin Biotech on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Moleculin Biotech or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moleculin Biotech vs. Cyclacel Pharmaceuticals
Performance |
| Timeline |
| Moleculin Biotech |
| Cyclacel Pharmaceuticals |
Moleculin Biotech and Cyclacel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moleculin Biotech and Cyclacel Pharmaceuticals
The main advantage of trading using opposite Moleculin Biotech and Cyclacel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moleculin Biotech position performs unexpectedly, Cyclacel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclacel Pharmaceuticals will offset losses from the drop in Cyclacel Pharmaceuticals' long position.| Moleculin Biotech vs. Eliem Therapeutics | Moleculin Biotech vs. Scpharmaceuticals | Moleculin Biotech vs. Milestone Pharmaceuticals | Moleculin Biotech vs. Seres Therapeutics |
| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |